Nomura Holdings’s Biolase, Inc. BIOL Stock Holding History

Nomura Holdings’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1	Closed	-$19K	–	1693
2016 Q1	$19K	Buy	+1	New	+$12.5K	﹤0.01%	1489

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

PCMI

Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nomura Holdings's BIOL Position: Q2 2016 in Review

Nomura Holdings sold out of Biolase, Inc. (BIOL) in Q2 2016, closing a stake of 1 share — an estimated $19K sold.

Nomura Holdings first reported a position in BIOL in Q1 2016 and held it in 1 quarter. The position peaked at $19K in Q1 2016. 35 funds tracked by Wall St. Rank hold BIOL as of Q2 2016.

Nomura Holdings reported no remaining Biolase, Inc. position as of Q2 2016 after selling out during the quarter.
Nomura Holdings sold 1 Biolase, Inc. share in Q2 2016, an estimated $19K.
Nomura Holdings first reported a position in Biolase, Inc. in Q1 2016 and held it in 1 quarter.
Nomura Holdings's Biolase, Inc. position peaked at $19K in Q1 2016.
35 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.